Literature DB >> 3192143

Postmortem diagnosis of diabetes mellitus. Quantitation of fructosamine and glycated hemoglobin.

A Valenzuela1.   

Abstract

Fructosamine and glycated hemoglobin were determined in samples from 52 cadavers autopsied in the Forensic Pathology Institute of the University of Copenhagen (Denmark). The population studied comprised 15 adult subjects with history of diabetes mellitus and 37 adult non-diabetic subjects. The fructosamine/total protein ratio was 1.7 times higher in diabetic than in non-diabetic subjects, as was the case for glycated hemoglobin. Measurement of glycated serum protein appears to be a useful tool for the postmortem diagnosis of fatal diabetic coma and glucose concentration before death.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3192143     DOI: 10.1016/0379-0738(88)90167-3

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  5 in total

1.  Armanni-Ebstein lesion, ketoacidosis and starvation in a child.

Authors:  C M Milroy; J L Parai
Journal:  Forensic Sci Med Pathol       Date:  2011-01-07       Impact factor: 2.007

2.  Alcoholism and the Armanni-Ebstein lesion.

Authors:  Jacqueline L Parai; Sarathchandra Kodikara; Christopher M Milroy; Michael S Pollanen
Journal:  Forensic Sci Med Pathol       Date:  2011-07-31       Impact factor: 2.007

3.  Combined determination of glucose and fructosamine in vitreous humor as a post-mortem tool to identify antemortem hyperglycemia.

Authors:  Guillermo Vivero; Guillermo Vivero-Salmerón; Maria D Pérez Cárceles; Andrés Bedate; Aurelio Luna; Eduardo Osuna
Journal:  Rev Diabet Stud       Date:  2009-02-10

4.  Preliminary results on the postmortem measurement of 3-beta-hydroxybutyrate in liver homogenates.

Authors:  Cristian Palmiere; Patrice Mangin; Dominique Werner
Journal:  Int J Legal Med       Date:  2013-05-31       Impact factor: 2.686

Review 5.  Postmortem diagnosis of diabetes mellitus and its complications.

Authors:  Cristian Palmiere
Journal:  Croat Med J       Date:  2015-06       Impact factor: 1.351

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.